Blocking HTLV-1/2 silent transmission in Brazil: Current public health policies and proposal for additional strategies
- PMID: 34555019
- PMCID: PMC8460035
- DOI: 10.1371/journal.pntd.0009717
Blocking HTLV-1/2 silent transmission in Brazil: Current public health policies and proposal for additional strategies
Abstract
Human T-cell lymphotropic viruses 1 and 2 (HTLV-1/2) are relatively common in Brazil but remain silent and neglected infections. HTLV-1 is associated with a range of diseases with high morbidity and mortality. There is no curative treatment for this lifelong infection, so measures to prevent transmission are essential. This narrative review discusses HTLV-1/2 transmission routes and measures to prevent its continuous dissemination. The public health policies that are currently implemented in Brazil to avoid HTLV-1/2 transmission are addressed, and further strategies are proposed.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
-
- CGIST/DDCI/SVS C-G de V das IST, Rosadas C, Espinosa Miranda A, Utscg Gonçalves D, Caterino-de-Araujo A, Assone T, et al. Prevalência da Infecção por HTLV-1/2 no Brasil. Bol Epidemiológico. 2020;51. Available: https://www.gov.br/saude/pt-br/media/pdf/2020/dezembro/11/boletim_epidem...
-
- Rosadas C, Assone T, Yamashita M, Adonis A, Puccioni-Sohler M, Santos M, et al. Health state utility values in people living with htlv-1 and in patients with ham/tsp: The impact of a neglected disease on the quality of life. PLoS Negl Trop Dis. 2020;14. doi: 10.1371/journal.pntd.0008761 - DOI - PMC - PubMed
-
- Gascón MRP, Capitão CG, Casseb J, Nogueira-Martins MCF, Smid J, Oliveira ACP. de. Prevalence of anxiety, depression and quality of life in HTLV-1 infected patients. Braz J Infect Dis. 15: 578–82. Available. http://www.ncbi.nlm.nih.gov/pubmed/22218518. doi: 10.1590/s1413-86702011000600013 - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
